Randomized controlled trial evaluating single port thoracic surgery with x-Gate for spontaneous pneumothorax.

Randomized controlled trial evaluating single port thoracic surgery with x-Gate for spontaneous pneumothorax. - Randomized controlled trial evaluating single port thoracic surgery with x-Gate for spontaneous pneumothorax.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031085

Enrollment

Registered

2018-03-20

Start date

2018-07-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spontaneous pneumothorax

Interventions

single-port thoracoscopic surgery with x-GATE conventional three-port thoracoscopic surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who have spontaneous pneumothorax, and the lesion (bulla or bleb) is located in the apex or peripheral side of lung. (2) Patients who are over 15 years and under 35 of age at the time of consent. (3) Patients who received informed consent to attend this study, and the agreements are provided in a document.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary pneumothorax. (2) Patients with severe liver or renal diseases. (3) Patients with severe allergy. (4) Patients who are judged ineligible by the investigator and the attending surgeon

Design outcomes

Primary

Measure	Time frame
degree of postoperative pain (POD 7, Visual Analogue Scale(VAS))	—

Secondary

Measure	Time frame
pneumothorax recurrence, intraoperative blood loss, operation time, frequency of intraoperative and postoperative complications, duration of drainage, postoperative hospital stay	—

Countries

Japan

Contacts

Public ContactDaisuke Hokka

Kobe University Graduate School of Medicine Division of Thoracic Surgery

dhokka@med.kobe-u.ac.jp0783825750

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026